Apr 04, 2016 11:30 am UTC| Business
WALTHAM, Mass., April 04, 2016 -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has acquired Atoll GmBH (“Atoll”) of Weingarten,...
Cempra to Present Data on Solithromycin at ECCMID
Apr 04, 2016 11:30 am UTC| Business
CHAPEL HILL, N.C., April 04, 2016 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious...
ConforMIS Announces Update on iTotal Hip
Apr 04, 2016 11:30 am UTC| Business
BEDFORD, Mass., April 04, 2016 -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient's unique anatomy, today announced an update on its...
Apr 04, 2016 11:30 am UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., April 04, 2016 -- Strongbridge Biopharma plc (Nasdaq:SBBP), a global rare disease biopharmaceutical company focused on the development and commercialization of novel therapeutic...
Apr 04, 2016 11:30 am UTC| Business
SOUTH SAN FRANCISCO, Calif., April 04, 2016 -- Cytokinetics, Inc. (Nasdaq:CYTK) today announced the start of a double-blind, randomized, placebo-controlled, multi-center Phase 2 clinical trial to evaluate the safety,...
Apr 04, 2016 11:30 am UTC| Business
SAN DIEGO, April 04, 2016 -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced the...
Navios Maritime Holdings Inc. Regains Compliance with NYSE Continued Listing Requirements
Apr 04, 2016 11:11 am UTC| Business
MONACO, April 04, 2016 -- Navios Maritime Holdings Inc.(“Navios Holdings” or the “Company”)(NYSE:NM) announced today that, based upon a notice received on April 1, 2016 from the New York Stock Exchange, Inc. (“NYSE”),...